Theriva Biologics (TOVX) Stock Jumps 63% After Pancreatic Cancer Trial Data Drops at AACR
TLDR Theriva Biologics (TOVX) stock jumped 63% after releasing new data from its VIRAGE Phase 2b trial VCN-01 plus standard chemotherapy showed improved overall survival...












